首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma
【24h】

Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma

机译:miR-26a和MEG3在舌鳞癌中的表达,调控及其作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

MicroRNA miR-26a and long noncoding RNA (incRNA) AAEG3 gene have been independently reported to be tumor suppressor genes in various cancers, but neither has been previously associated with tongue squamous cell carcinoma (TSCC). We report here that miR-26a and IncRNA MEG3 gene expression were both strongly reduced in TSCC compared with levels in matched nonmalignant tissues, and combined low expression levels of both miR-26a and AAEG3 emerged as an independent prognostic factor for poor clinical outcome in TSCC patients. Assays in the human TSCC cell lines SCC-15 and CAL27 showed that miR-26a targets the DNA methyltransferase 3B transcript and that its inhibition may result in the upregulation of MEG3, providing a plausible link between the observed reduction of miR-26a and MEG3 in TSCC tissue. Furthermore, the overexpression of miR-26a or MEG3 in SCC-15 and CAL27 cells inhibited cell proliferation and cell cycle progression, and promoted cell apopto-sis. Considering the poor prognostic outcomes associated with reduced miR-26a and MEG3, our findings imply that these factors likely play important antitumor effects in TSCC pathogenesis. Furthermore, they represent potential prognostic biomarkers for stratification of TSCC patients.
机译:MicroRNA miR-26a和长非编码RNA(incRNA)AAEG3基因已被独立报道为多种癌症中的肿瘤抑制基因,但以前均未与舌鳞状细胞癌(TSCC)相关。我们在这里报告,与匹配的非恶性组织中的水平相比,TSR中的miR-26a和IncRNA MEG3基因表达均大大降低,并且miR-26a和AAEG3的联合低表达水平已成为TSCC临床预后不良的独立预后因素耐心。在人TSCC细胞系SCC-15和CAL27中的分析表明,miR-26a靶向DNA甲基转移酶3B转录本,其抑制作用可能导致MEG3上调,从而在观察到的miR-26a和MEG3还原之间提供了合理的联系。 TSCC组织。此外,miR-26a或MEG3在SCC-15和CAL27细胞中的过表达抑制细胞增殖和细胞周期进程,并促进细胞凋亡。考虑到与miR-26a和MEG3减少相关的不良预后,我们的发现暗示这些因素可能在TSCC发病机理中起重要的抗肿瘤作用。此外,它们代表了TSCC患者分层的潜在预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号